BerandaCYCCP • NASDAQ
add
Cyclacel Pharmaceuticals Inc Conv. Pref. Shrs
Tutup sebelumnya
$4,61
Rentang hari
$4,46 - $4,88
Rentang tahun
$3,20 - $17,00
Kapitalisasi pasar
99,67Â jt USD
Volume Rata-Rata
1,20Â rb
Rasio P/E
-
Hasil dividen
13,33%
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 0,00 | -100,00% |
Biaya operasional | 1,83Â jt | -66,09% |
Laba bersih | -3,05Â jt | 42,10% |
Margin laba bersih | — | — |
Penghasilan per saham | — | — |
EBITDA | -1,83Â jt | 65,86% |
Tarif pajak efektif | -64,26% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 3,14Â jt | -7,13% |
Total aset | 4,09Â jt | -53,50% |
Total liabilitas | 6,27Â jt | -23,54% |
Total ekuitas | -2,17 jt | — |
Saham yang beredar | 207,34 jt | — |
Harga terhadap nilai buku | -18,44 | — |
Tingkat pengembalian aset | -96,46% | — |
Tingkat pengembalian modal | 290,71% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -3,05Â jt | 42,10% |
Kas dari operasi | -1,36Â jt | 65,32% |
Kas dari investasi | — | — |
Kas dari pembiayaan | 1,61Â jt | 61,46% |
Perubahan kas bersih | 155,00Â rb | 106,04% |
Arus kas bebas | 262,50Â rb | 113,79% |
Tentang
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Dundee, Scotland, and Short Hills, New Jersey, developing cancer drugs and treatments. Cyclacel was founded in 1996 by David Lane, Merlin Ventures and Cancer Research Campaign Technology with the University of Dundee and the University of Glasgow. Wikipedia
Didirikan
13 Agu 1996
Kantor pusat
Situs
Karyawan
12
